TABLE 1

Baseline characteristics of study participants

Intervention groupControl groupP*PP
Age (years)54 ± 8 (52)53 ± 7 (49)0.615
Weight (kg)86.1 ± 14.2 (52)87.8 ± 15.7 (49)0.6340.945
BMI (kg/m2)30.9 ± 4.0 (52)31.7 ± 5.0 (49)0.5960.740
Waist circumference (cm)104.3 ± 10.6 (51)104.0 ± 10.9 (49)0.9810.6890.134
Fasting glucose (mmol/l)6.3 ± 0.8 (51)6.5 ± 0.8 (49)0.2620.1590.182
2-h glucose (mmol/l)9.1 ± 1.5 (51)9.3 ± 1.7 (49)0.6120.6100.631
Fasting insulin (pmol/l)83.5 ± 38.0 (49)103.6 ± 58.6 (48)0.1340.1100.128
2-h insulin (pmol/l)616.3 ± 411.6 (38)632.2 ± 402.0 (36)0.7460.7260.855
HbA1c (%)5.9 ± 0.9 (50)5.8 ± 1.0 (47)0.6570.6810.688
AIR (mU · l−1 · min−1)281 ± 286 (47)259 ± 266 (40)0.7620.5840.585
Si (×10−4 · min−1 · μU−1 · ml−1)1.85 ± 1.28 (47)1.99 ± 1.38 (39)0.5880.6480.632
Sg ([min]−1 · 102)1.50 ± 0.51 (47)1.52 ± 0.48 (40)0.9360.8410.828
  • Data are mean ± SD (n).

  • *

    * P value after adjustment for age and sex.

  • P value after adjustment for age, sex, and BMI.